FDA has gathered their information on SPL Indexing here
There is now a table that links all the active moieties to the FDA's determination of established pharmacologic class here.
Notes from SPL Indexing Overview at Process / Communication Forum Feb 10 here.
In June 2008 FDA published the final guidance on SPL Indexing.
The indexing of the content of labeling for human drug and biological products using SPL (Structured Product Labeling) will be conducted by FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER).
Applicants can participate in the SPL indexing process. Having consistently and accurately indexed content of labeling is an important step toward the creation of a fully automated health information exchange system.
Tools that might be useful for further access and searching of complex terminologies such as SNOMED:
SPL Indexing
Overview
FDA has gathered their information on SPL Indexing here
There is now a table that links all the active moieties to the FDA's determination of established pharmacologic class here.
Questions about assigned term(s): Address to SEALD@fda.hhs.gov
Notes from SPL Indexing Overview at Process / Communication Forum Feb 10 here.
In June 2008 FDA published the final guidance on SPL Indexing.
Tools that might be useful for further access and searching of complex terminologies such as SNOMED:
Established Pharmacologic Class
A sample file of an established pharmacologic class SPL:SPL Resources Page containing Terminology for Indexing:
An introduction to SPL Indexing, using an OTC example: